These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 792334)

  • 1. Anti-lymphokine antibody. II. Specificity of biological activity.
    Kuratsuji T; Yoshida T; Cohen S
    J Immunol; 1976 Nov; 117(5 Pt.2):1985-91. PubMed ID: 792334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to guinea pig lymphokines. IV. Suppression of the mixed leukocyte culture reaction by anti-lymphokine globulin.
    Geczy CL; Geczy AF; De Weck AL
    J Immunol; 1976 Nov; 117(5 Pt.2):1824-31. PubMed ID: 136471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The production of anti-guinea pig lymphokine antibody.
    Yoshida T; Bigazzi PE; Cohen S
    J Immunol; 1975 Feb; 114(2 Pt 1):688-91. PubMed ID: 1091701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to guinea pig lymphokines. II. Suppression of delayed hypersensitivity reactions by a "second generation" goat antibody against guinea pig lymphokines.
    Geczy CL; Geczy AF; De Weck AL
    J Immunol; 1976 Jul; 117(1):66-72. PubMed ID: 1084371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to guinea pig lymphokines. III. Reactions with radiolabeled lymphocyte activation products.
    Sorg C; Geczy CL
    Eur J Immunol; 1976 Oct; 6(10):688-93. PubMed ID: 797284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte chemotaxis in inflammation. VIII. Demonstration of lymphocyte chemotactic lymphokines in PPD-induced delayed hypersensitivity skin reaction site in the guinea-pig.
    Shimokawa Y; Harita S; Mibu Y; Hayashi H
    Immunology; 1984 Feb; 51(2):287-94. PubMed ID: 6693135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on lymphokines: the production of antibody to guinea pig lymphotoxin and its use to distinguish lymphotoxin from migration inhibitory factor and mitogenic factor.
    Gately MK; Gately CL; Henney CS; Mayer MM
    J Immunol; 1975 Sep; 115(3):817-26. PubMed ID: 1097529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization: effects on cutaneous and peritoneal manifestations of delayed hypersensitivity in relation to lymphokine production.
    Sonozaki H; Papermaster V; Yoshida T; Cohen S
    J Immunol; 1975 Dec; 115(6):1657-61. PubMed ID: 1102607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to guinea pig lymphokines. VII. Reactivity with products of lymphoid and nonlymphoid cells.
    Sorg C; Geczy CL
    J Immunol; 1978 Sep; 121(3):1199-205. PubMed ID: 99476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphokine-like factors produced by human lymphoid cell lines with B or T cell surface markers.
    Yoshida T; Kuratsuji T; Takada A; Takada Y; Minowada J; Cohen S
    J Immunol; 1976 Aug; 117(2):548-54. PubMed ID: 781133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. II. Production and characterization of an anti-MIF antibody.
    Fahlbusch B; Metzner G; Schumann I; Tittel R
    Biomed Biochim Acta; 1986; 45(3):371-84. PubMed ID: 3518711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of macrophage migration inhibitory factor activity produced in vivo by a cell-mediated immune reaction in the guinea pig.
    Postlethywaite AE; Townes AS; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1716-20. PubMed ID: 794416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charge-reducing lymphokine activity in Concanavalin A-stimulated lymphocyte supernatants: preliminary biological and biochemical characterization.
    Kotzsch M; Grossmann H; Irmscher J; Wagner H; Müller M
    Biomed Biochim Acta; 1984; 43(1):57-65. PubMed ID: 6372798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotaxis of basophils by lymphocyte-dependent and lymphocyte-independent mechanisms.
    Ward PA; Dvorak HF; Cohen S; Yoshida T; Data R; Selvaggio SS
    J Immunol; 1975 May; 114(5):1523-31. PubMed ID: 1091704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphokines. II. Use of horse monocytes as indicator cells for human MIF.
    Friedrich W; Lazary S; de Weck AL
    Int Arch Allergy Appl Immunol; 1976; 50(2):142-54. PubMed ID: 1107231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.
    Schreiber RD; Hicks LJ; Celada A; Buchmeier NA; Gray PW
    J Immunol; 1985 Mar; 134(3):1609-18. PubMed ID: 2578513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucocyte chemotactic activity in the parallel bioassay of guinea--pig lymphokines.
    DeFranco MF; Hanson JM; Morley J; Wolstencroft RA; Dumonde DC
    Immunology; 1977 Feb; 32(2):179-90. PubMed ID: 844893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokines in sensitized rats. I. Migration inhibitory factor(s) from specifically stimulated thymocytes in vitro.
    Bakker WW; Engelhart JJ; Mulder I; Hoedemaeker PJ
    Int Arch Allergy Appl Immunol; 1975; 49(4):491-503. PubMed ID: 1099009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of protective immunity against tuberculosis and tuberculin hypersensitivity at a level of lymphokines.
    Hashimoto T; Onozaki K; Homma Y; Fukutomi Y; Ichikawa M
    Dev Biol Stand; 1986; 58 ( Pt B)():553-9. PubMed ID: 3609455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.